Rani Therapeutics Inc. (RANI)

AI Score

Unlock

1.17

0.02 (1.74%)

At close: Apr 17, 2025, 3:59 PM

1.16

-1.00%

After-hours: Apr 17, 2025, 07:41 PM EDT

Rani Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	3.76M	4.28M	4.51M	7.38M	6.36M	4.97M	7.55M	18.98M	27.01M	27.22M	97.18M	107.84M	117.45M	129.74M	69.31M	76.66M	73.06M
Short-Term Investments	23.88M	26.13M	26.39M	32.7M	42.67M	55.55M	67.05M	67.8M	71.47M	70.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	246K	246K	246K	246K	546K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.41M	785K	n/a
Receivables	428K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-200K	-200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.68M	1.97M	1.13M	666K	2.31M	2.7M	1.77M	2.25M	2.44M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	29.74M	32.37M	32.03M	41.39M	50.55M	63.22M	76.37M	89.04M	100.92M	100.72M	97.99M	109.26M	119.59M	132.37M	69.48M	76.8M	74.94M
Property-Plant & Equipment	6.64M	10.92M	11.45M	11.88M	6.82M	7.21M	7.13M	7.41M	7.1M	6.98M	6.35M	6.05M	4.61M	4.59M	4.43M	4.49M	4.47M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	6.89M	11.17M	11.69M	12.12M	7.37M	7.21M	7.13M	7.41M	7.1M	7.48M	6.35M	6.05M	4.61M	4.59M	7.84M	5.28M	4.47M
Total Assets	36.63M	43.54M	43.73M	53.51M	57.92M	70.44M	83.51M	96.45M	108.03M	108.2M	104.34M	115.31M	124.21M	136.96M	77.32M	82.08M	79.42M
Account Payables	1.36M	1.57M	506K	806K	648K	1.41M	1.04M	1.51M	1.46M	1.79M	1.44M	1.26M	1.08M	1.31M	1.67M	943K	537K
Deferred Revenue	n/a	600K	n/a	n/a	n/a	n/a	3.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.45M	1.96M	2.72M
Short-Term Debt	15M	16.18M	13.65M	8.59M	5.62M	1.22M	856K	n/a	1.01M	984K	658K	650K	n/a	n/a	3.88M	1.95M	1.36M
Other Current Liabilities	283K	133K	788K	1.62M	695K	1.95M	595K	360K	995K	423K	556K	341K	126K	860K	1.88M	853K	2.86M
Total Current Liabilities	19.89M	20.21M	16.58M	13.38M	7.99M	7.34M	5.74M	5.15M	4.82M	7.19M	5.35M	4.16M	2.64M	5.25M	9.36M	7.09M	5.31M
Long-Term Debt	9.61M	13.54M	17.21M	20.85M	24.48M	28.1M	29.27M	29.21M	29.15M	14.09M	n/a	n/a	n/a	n/a	n/a	1.89M	2.41M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	191.64M	191.57M	185.03M
Total Long-Term Liabilities	13.25M	17.55M	21.59M	25.6M	24.48M	28.27M	29.6M	29.71M	29.21M	14.41M	341K	509K	1.08M	n/a	191.64M	193.46M	187.45M
Total Liabilities	33.14M	37.77M	38.18M	38.98M	32.47M	35.62M	35.34M	34.86M	34.02M	21.59M	5.69M	4.67M	2.64M	5.25M	201M	200.55M	192.75M
Total Debt	29.71M	33.73M	35.25M	35.41M	30.1M	30.28M	30.46M	30.63M	30.21M	15.39M	999K	1.16M	n/a	n/a	3.88M	3.84M	3.77M
Common Stock	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	1.41M	1.13M	664K
Retained Earnings	-102.91M	-93.96M	-87.18M	-80.37M	-72.89M	-65.79M	-56.59M	-47.29M	-38.92M	-30.13M	-22.18M	-14.55M	-8.33M	-3.14M	-125.09M	-119.6M	-114M
Comprehensive Income	5K	8K	-5K	-11K	-12K	-41K	-63K	-10K	-73K	-57K	-0.00	-0.00	-0.00	-136.96M	-0.00	-192.7M	n/a
Shareholders Equity	1.99M	3.12M	2.83M	7.4M	12.87M	17.55M	24.09M	30.72M	36.85M	42.19M	47.81M	53.38M	47.41M	51.37M	-123.67M	-118.47M	-113.34M
Total Investments	23.88M	26.13M	26.39M	32.7M	42.67M	55.55M	67.05M	67.8M	71.47M	70.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a